Monitor for Form 4 filing confirming actual sale. The intent to sell is routine for RSU vesting but could signal management's view if followed by additional filings. Given the company's positive analyst consensus, this single filing is unlikely to materially impact the stock.
Price Chart
Executive Summary
Officer Jonathan Gillis filed a Form 144 indicating intent to sell 69,835 shares of MapLight Therapeutics (MPLT) worth approximately $2.08 million. The shares were acquired via RSU vesting and pre-IPO grants. While the sale size is modest relative to the $1.3B market cap, it represents a notable increase over recent insider selling activity.
Key Facts
- Insider: Jonathan Gillis (Officer) intends to sell 69,835 shares
- Estimated value: $2,078,289.60 based on ~$29.76/share
- Shares acquired from RSU vesting (07/05/2024–04/01/2026) and pre-IPO restricted shares
- Filing date: April 27, 2026; sale may occur soon
- Recent 30-day insider selling: 10 transactions totaling $594K
Financial Impact
Sale of 69,835 shares valued at ~$2.08M, representing ~0.16% of outstanding shares
Risk Factors
- Potential perception of insider bearishness if sale is executed amid weak catalyst environment
- Accumulation of insider selling could weigh on sentiment over time
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-003775 |
| Document: 0001950047-26-003775-index.html | 0001950047-26-003775 |
| Document: 0001950047-26-003775.txt | 0001950047-26-003775 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.66 (+4.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.66 (−28.81%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.66 (−29.72%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.66 (−40.71%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.66 (−40.80%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.66 (+41.17%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.66 (−49.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers